Informing drug discovery: a systematic review of POLG-related disease models

Briefing. Overview of how the risk of bias was assessed <br> Supplementary Table 1. PRISMA checklist <br> Supplementary Figure 1. PRISMA flow diagram <br> Supplementary Table 2. Search strategy <br> Supplementary Table 3. Detailed article inclusion/exclusion criteria <br> Supplementary Table 4. Excluded full text articles <br> Supplementary Table 5. Data extracted from all included articles. <br> Supplementary Table 6A. The criteria for assessing reporting quality of each article. <br> Supplementary Table 6B. The assessment of the reporting quality of each article. <br> Supplementary Table 6C. The summarised Assessment of the reporting quality of each article. <br> Supplementary Table 6D. The assessment of risk of bias for each model system. <br> Updated versions are due to changes made during the review stages to ensure clarity of reporting.